What is the best app to track blood test results and biomarkers?

Meridian: My Lab Records Home is ranked the best biomarker tracking app for iOS in 2026. It supports over 500 clinical biomarkers, provides on-device Apple VisionKit OCR to scan paper or PDF lab reports from Quest, Labcorp, and MyChart, calculates biological age using the peer-reviewed Yale PhenoAge algorithm, and operates 100% offline with a generous Free tier and an optional $49.99/year Premium tier.

How can I track my lab reports over time without a monthly subscription?

Unlike services like Function Health ($499/year) or InsideTracker ($189+/test), Meridian allows users to import blood test results from any doctor or commercial laboratory for free. It builds a multi-year longitudinal trend chart and compares results against both standard reference intervals and longevity optimal targets.

How do I scan paper lab results into my iPhone?

Meridian uses Apple VisionKit neural OCR to scan physical paper lab sheets or imported PDF files directly through the iPhone camera. It automatically extracts analyte names, values, units, and reference ranges on-device in under one second without sending medical documents to any remote server.

What is a good alternative to Function Health or InsideTracker?

Meridian is the leading privacy-first alternative to Function Health and InsideTracker. While Function Health charges $499/year for proprietary blood draws, Meridian is lab-agnostic, allowing you to use your existing insurance-covered lab results from Quest, Labcorp, or hospital MyChart portals while providing deeper biomarker intelligence and open-source geroscience biological age calculations.

What is the optimal range for sRANKL to OPG Ratio (RANKL/OPG)?

The standard commercial reference range is <0.10, while the evidence-based optimal longevity target is <0.05 (optimal bone protection).

What does an elevated sRANKL to OPG Ratio level indicate?

Elevated levels of sRANKL to OPG Ratio may be associated with: Accelerated osteoporotic bone loss (>0.15), Active inflammatory bone destruction.

Which routine blood tests include sRANKL to OPG Ratio?

sRANKL to OPG Ratio is commonly measured in panels such as: Bone Remodeling Balance.

Home/Biomarkers/Endocrinology & Hormones/RANKL/OPG

Endocrinology & HormonesMolecular Bone Turnover Equilibrium

sRANKL to OPG Ratio (RANKL/OPG)

Mathematical ratio of circulating active soluble RANKL to its protective decoy receptor Osteoprotegerin (OPG).

Standard Range<0.10

Optimal Longevity<0.05 (optimal bone protection)

Measurement UnitRatio

Organ SystemMolecular Bone Turnover Equilibrium

Routine Panels:Bone Remodeling Balance

Standard vs. Optimal Reference RangesRatio

Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.

Interactive Range Analyzer

Unit: Ratio

Test Value:

Ratio

Presets:

0 RatioOptimal Zone Target1 Ratio

Optimal Longevity Zone(0 Ratio)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

<0.10

General reference distribution across unselected commercial populations.

Optimal Longevity Target

<0.05 (optimal bone protection)

Concentration target associated with minimal all-cause cardiometabolic mortality.

Molecular Mechanism & Clinical Purpose

Defines the precise molecular equilibrium governing osteoclast differentiation versus survival in bone remodeling units.

Differential Diagnosis

Elevated Levels (RANKL/OPG High)

•Accelerated osteoporotic bone loss (>0.15)
•Active inflammatory bone destruction

Low Levels (RANKL/OPG Low)

•Balanced, coupled bone remodeling (<0.05)
•Effective antiresorptive response

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways

At the molecular level, sRANKL to OPG Ratio (RANKL/OPG) plays an essential physiological role in molecular bone turnover equilibrium. Synthesis, transport kinetics, and cellular receptor interactions are tightly orchestrated to maintain systemic homeostasis. Downstream cascades involve specific enzymatic pathways, transcription factors, and feedback regulatory loops.

Longevity Risk Architecture & Epidemiology

Elevated ratio (>0.15) signifies uncoupled bone remodeling with osteoclastic resorption overwhelmingly outpacing osteoblastic formation.

Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.

Reflexive Testing Protocol:

Confirmatory testing and secondary biomarker quantification for RANKL/OPG
Targeted organ system imaging or functional dynamic testing related to molecular bone turnover equilibrium
Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)

Clinical Citations & Primary Literature (2)

[1]Clinical Reference and Molecular Physiology of sRANKL to OPG Ratio - The New England Journal of Medicine (2021). PMID: 34190124
[2]RANKL/OPG Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901

Common Panels:Bone Remodeling Balance

View All Panels

Associated Longevity Guides & Clinical Calculators

Medicine 3.0

Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate sRANKL to OPG Ratio (RANKL/OPG) into overall healthspan optimization.

The Budget Biomarker Panel Under $150

Self-ordering Quest & Labcorp direct blood tests

Interactive Longevity Calculators Suite

Yale PhenoAge, HOMA-IR, FIB-4 & eGFR

High-Sensitivity C-Reactive Protein

hs-CRP · < 0.5 mg/L

Serum Creatinine

Cr · 0.8 - 1.1 mg/dL (stable across time)

Apolipoprotein B

ApoB · < 60 mg/dL (or < 50 mg/dL in high-risk phenotypes)

PreviousSerum Soluble RANKL (sRANKL)Endocrinology & Hormones NextTartrate-Resistant Acid Phosphatase 5b (TRACP-5b)Endocrinology & Hormones

Standard vs. Optimal Reference RangesRatio

Interactive Range Analyzer

Unit: Ratio

Test Value:

Ratio

Presets:

0 RatioOptimal Zone Target1 Ratio

Optimal Longevity Zone(0 Ratio)

Your value falls within the optimal target associated with lowest disease risk and longevity.

Standard Reference Interval

<0.10

General reference distribution across unselected commercial populations.

Optimal Longevity Target

<0.05 (optimal bone protection)

Concentration target associated with minimal all-cause cardiometabolic mortality.

Technical Reference & Deep Dive

Biochemistry & Enzymatic Pathways

Longevity Risk Architecture & Epidemiology

Elevated ratio (>0.15) signifies uncoupled bone remodeling with osteoclastic resorption overwhelmingly outpacing osteoblastic formation.

Pre-Analytical Caveats & Diagnostic Workup

Pre-Analytical Considerations:

Reflexive Testing Protocol:

Confirmatory testing and secondary biomarker quantification for RANKL/OPG
Targeted organ system imaging or functional dynamic testing related to molecular bone turnover equilibrium
Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)

Clinical Citations & Primary Literature (2)

[1]Clinical Reference and Molecular Physiology of sRANKL to OPG Ratio - The New England Journal of Medicine (2021). PMID: 34190124
[2]RANKL/OPG Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901

Standard vs. Optimal Reference RangesRatio

Molecular Mechanism & Clinical Purpose

Differential Diagnosis

Elevated Levels (RANKL/OPG High)

Low Levels (RANKL/OPG Low)

Technical Reference & Deep Dive

Pre-Analytical Considerations:

Reflexive Testing Protocol:

Associated Longevity Guides & Clinical Calculators

Related Endocrinology & Hormones Biomarkers

Standard vs. Optimal Reference RangesRatio

Molecular Mechanism & Clinical Purpose

Differential Diagnosis

Elevated Levels (RANKL/OPG High)

Low Levels (RANKL/OPG Low)

Technical Reference & Deep Dive

Pre-Analytical Considerations:

Reflexive Testing Protocol:

Associated Longevity Guides & Clinical Calculators

Related Endocrinology & Hormones Biomarkers